NFE2L2 and pancreatic neoplasm: Here, we have shown that brusatol inhibits the function of Nrf2 and lowers the expression levels of its target genes—members of the multidrug resistance (MDR) family that are involved in drug resistance in pancreatic tumours [21–23].